Piotr J. Wysocki
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Piotr J. Wysocki
Jul 17, 2024, 23:37 |
Blog
Ola Abuzaid: The End of an Unforgettable Journey with Jagiellonian University Department of Oncology
Ola Abuzaid, Medical Student at Erciyes University, shared on LinkedIn: "Today Marks the End of an…
Jun 20, 2024, 14:31 |
Blog
Haimanot Kasahun: It was a privilege to come to know Onyinye Balogun
Haimanot Kasahun, Clinical oncologist at Saint Pauls Hospital millennium medical college, shared a post on…
Jun 8, 2024, 09:37 |
Societies
Onyinye Balogun: Attending OncoDaily Yvonne Awards 2024 was certainly one of my ASCO24 highlights!
Onyinye Balogun, Co-Founder of Mission-Driven Tech, shared on LinkedIn: "Attending OncoDaily Yvonne Awards 2024 was…
Apr 12, 2024, 10:05 |
Drugs
Piotr J. Wysocki: Immunotherapy combined with tyrosine-kinase inhibitor is not better than docetaxel in NSCLS patients after first-line chemoimmunotherapy failure
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Apr 12, 2024, 09:11 |
Opinion
Piotr J. Wysocki: PSA screening does reduce prostate cancer mortality, but the overall benefit is small, according to a secondary analysis of the CAP trial
Piotr J. Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared a post…
Apr 5, 2024, 02:23 |
Insight
Piotr J. Wysocki: OPTICAL trial - another study demonstrating the feasibility and promising efficacy of neoadjuvant chemotherapy in locally advanced colon cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Apr 5, 2024, 01:51 |
Insight
Piotr J. Wysocki: Pembrolizumab significantly improves efficacy of chemoradiotherapy in patients with locally-advanced cervical cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 30, 2024, 11:36 |
Insight
Piotr J. Wysocki: Pembrolizumab remains the only drug active in adjuvant settings in RCC – updated results of the ECOG-ACRIN E2810 on adjuvant pazopanib
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 22, 2024, 23:32 |
Insight
Piotr J. Wysocki: Ribociclib combined with an aromatase inhibitor in the adjuvant treatment of breast cancer – interim analysis of Natalee study
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 22, 2024, 15:23 |
Blog
Piotr J. Wysocki: Regular, personalized follow-up in breast cancer survivors may not improve long-term outcomes but significantly improves patients’ quality of life
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a…
Mar 15, 2024, 15:26 |
Insight
Enfortumab+pembrolizumab combination as the 1st line treatment of choice for advanced urothelial cancer - summary by Piotr J. Wysocki
Piotr J. Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital,…
Mar 5, 2024, 20:12 |
Insight
Piotr J. Wysocki: Final results of the POUT trial support the use of adjuvant chemotherapy in upper tract urothelial cancer
Piotr J. Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University…
Mar 4, 2024, 17:27 |
Drugs
Piotr Wysocki: Anthracyclines must always be considered in the adjuvant treatment of breast cancer patients- final results of ABC trials
Piotr Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University Hospital…
Mar 3, 2024, 17:09 |
Blog
Christoph Zielinski: A big 'thank you' to the faculty and the host Piotr J. Wysocki for making the excellent 2nd CECOG on colon cancer possible
Christoph Zielinski, Medical Director of Wiener Privatklinik and President of the Central European Cooperative Oncology…
Feb 12, 2024, 15:23 |
Opinion
Piotr J. Wysocki: Do we finally have a promising screening method for ovarian cancer?
Piotr J. Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University…
Feb 8, 2024, 17:16 |
Blog
Highlights from the IV Armenian Oncology Congress
This year the IV Armenian Oncology Congress, held under the theme “Oncology in Armenia: Current Achievements and…
Feb 5, 2024, 02:47 |
Opinion
Piotr J. Wysocki: The Armenian Oncology Congress is an example of how oncology is developing extremely dynamically in this small but very ambitious country
Piotr J. Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University…
Nov 15, 2023, 19:26 |
Dialogues
OncoDaily Dialogues #2 - Piotr Wysocki / Hosted by Roupen Odabashian
We continue our series of “OncoDaily Dialogues”. This initiative by OncoDaily is designed to spotlight…
All:
18
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube